<p>Chemicals maker Anupam Rasayan India Ltd on Friday reported a multi-fold jump in its consolidated net profit at Rs 32.12 crore in the first quarter of 2021-22 fiscal.</p>.<p>The company had posted a net profit of 0.226 crore in the same quarter of the previous fiscal, according to the BSE filing.</p>.<p>Net revenue increased on a consolidated basis to Rs 237.9 crore in the April-June quarter of 2021-22 fiscal from Rs 134.6 crore in the year-ago period.</p>.<p>Expenses remained higher at Rs 194 crore as against 132.6 crore in the said period.</p>.<p>Commenting on the performance, the company's Managing Director Anand Desai said as a result of the company's timely debt repayment, the company's balance sheet has become leaner and more in line with the company's scale of operations.</p>.<p>"We have clearly defined strategic objectives of increasing capital efficiency, capturing profitable growth, and generating positive cash flow which will lead to a significant increase in RoE (Return on Equity) and RoCE (Return on Capital Employed)," he said.</p>.<p>He said the company will continue to increase its investments in research and development, especially in light of increasing inquiries received from major MNCs recently exhibiting promising market potential.</p>.<p>Shares of the company closed up 0.33 per cent at Rs 712.95 apiece on the BSE on Friday.</p>
<p>Chemicals maker Anupam Rasayan India Ltd on Friday reported a multi-fold jump in its consolidated net profit at Rs 32.12 crore in the first quarter of 2021-22 fiscal.</p>.<p>The company had posted a net profit of 0.226 crore in the same quarter of the previous fiscal, according to the BSE filing.</p>.<p>Net revenue increased on a consolidated basis to Rs 237.9 crore in the April-June quarter of 2021-22 fiscal from Rs 134.6 crore in the year-ago period.</p>.<p>Expenses remained higher at Rs 194 crore as against 132.6 crore in the said period.</p>.<p>Commenting on the performance, the company's Managing Director Anand Desai said as a result of the company's timely debt repayment, the company's balance sheet has become leaner and more in line with the company's scale of operations.</p>.<p>"We have clearly defined strategic objectives of increasing capital efficiency, capturing profitable growth, and generating positive cash flow which will lead to a significant increase in RoE (Return on Equity) and RoCE (Return on Capital Employed)," he said.</p>.<p>He said the company will continue to increase its investments in research and development, especially in light of increasing inquiries received from major MNCs recently exhibiting promising market potential.</p>.<p>Shares of the company closed up 0.33 per cent at Rs 712.95 apiece on the BSE on Friday.</p>